- Home
- PRTA vs MMU Comparison
PRTA vs MMU Comparison
Compare PRTA & MMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- MMU
- Stock Information
- Founded
- PRTA 2012
- MMU 1992
- Country
- PRTA Ireland
- MMU United States
- Employees
- PRTA N/A
- MMU N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- MMU Investment Managers
- Sector
- PRTA Health Care
- MMU Finance
- Exchange
- PRTA Nasdaq
- MMU Nasdaq
- Market Cap
- PRTA 643.0M
- MMU 562.0M
- IPO Year
- PRTA N/A
- MMU N/A
- Fundamental
- Price
- PRTA $13.77
- MMU $10.30
- Analyst Decision
- PRTA Buy
- MMU
- Analyst Count
- PRTA 7
- MMU 0
- Target Price
- PRTA $46.50
- MMU N/A
- AVG Volume (30 Days)
- PRTA 711.1K
- MMU 170.7K
- Earning Date
- PRTA 02-13-2025
- MMU 01-01-0001
- Dividend Yield
- PRTA N/A
- MMU 4.92%
- EPS Growth
- PRTA N/A
- MMU N/A
- EPS
- PRTA N/A
- MMU N/A
- Revenue
- PRTA $133,350,000.00
- MMU N/A
- Revenue This Year
- PRTA $56.89
- MMU N/A
- Revenue Next Year
- PRTA N/A
- MMU N/A
- P/E Ratio
- PRTA N/A
- MMU N/A
- Revenue Growth
- PRTA N/A
- MMU N/A
- 52 Week Low
- PRTA $11.70
- MMU $8.60
- 52 Week High
- PRTA $34.75
- MMU $10.45
- Technical
- Relative Strength Index (RSI)
- PRTA 48.19
- MMU 51.12
- Support Level
- PRTA $12.39
- MMU $10.07
- Resistance Level
- PRTA $13.64
- MMU $10.36
- Average True Range (ATR)
- PRTA 1.03
- MMU 0.12
- MACD
- PRTA -0.02
- MMU 0.02
- Stochastic Oscillator
- PRTA 40.47
- MMU 68.79
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About MMU Western Asset Managed Municipals Fund Inc.
Western Asset Managed Municipals Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is to maximize current income exempted from federal income tax as is consistent with the preservation of principal. It predominantly invests in long-term investment grade municipal debt securities issued by state and local governments, political subdivisions, agencies, and public authorities (municipal obligations). Under normal market conditions, a majority of its total assets are invested in municipal obligations rated investment grade at the time of investment.